Chronic pain management platform FlexifyMe has successfully closed its seed funding round, securing INR 10 Crore from leading investors IvyCap Ventures and Flipkart Ventures. The round witnessed active participation from other esteemed investors, including GSF, Chandigarh Angels, Venture Catalyst, and Ah Ventures.
Utilizing these funds strategically, the company aims to revolutionize chronic pain management by integrating state-of-the-art technology and progressive exercises. The primary objective is to provide long-lasting relief and elevate workplace wellness to new heights.
Experienced by more than 2 billion people globally, chronic pain is heightened by sedentary lifestyles and postural misalignments. FlexifyMe, India’s foremost chronic pain management solution, intends to use the funds to strengthen its technology and implement progressive exercises. The company’s primary goal is to help businesses understand ergonomic challenges, eliminate postural misalignments, improve employee productivity, and ensure ongoing health monitoring—ultimately fostering stress reduction and enhancing overall lifestyle disorders.
FlexifyMe’s Innovative AI Motion-Tracking Technology
Distinguished as the leading Indian company providing a comprehensive solution for chronic pain management, FlexifyMe stands out. Leveraging patented AI-based software that analyzes joint movements, the platform connects users with expert Orthos, Physiotherapists, and Yoga therapists, offering a permanent solution to chronic pain. With a user base surpassing 50,000 from 26 countries, FlexifyMe has established itself as a global leader in digital therapeutics.
Founded in October 2021 by experienced entrepreneurs Manjeet Singh and Amit Bhayani, FlexifyMe is dedicated to reshaping traditional physiotherapy with its revolutionary AI motion-tracking technology.
Speaking about the investment, Vikram Gupta, Founder and Managing Partner, said, “FlexifyMe’s innovative approach convinced us of its potential to revolutionize healthcare. We believe in the power of FlexifyMe’s unique platform, backed by its dedicated team, to transform the lives of millions suffering from chronic pain. The ambitious goals set by the founders align seamlessly with our vision for impactful investments.”
Speaking about the company’s journey and future endeavors, Co-Founders Manjeet Singh and Amit Bhayani express, “Utilizing AI, machine learning, and data analytics, we provide personalized Chronic Pain Management. The gratitude we feel for the investment round and the trust bestowed by our investors in our vision is immense. Our commitment is to harness advanced technology in healthcare to aid one million individuals in finding relief from chronic pain by 2027.”
Chronic pain and musculoskeletal disorders remain a significant global healthcare challenge. FlexifyMe is committed to transforming healthcare through its technology-driven solutions. In the short term, the company is dedicated to achieving clinical validation and FDA approval, crucial steps to enhance its credibility. In the long term, FlexifyMe emphasizes its commitment to global accessibility through strategic partnerships with insurance companies, hospitals, and multinational corporations.
Continue Exploring: Sexual wellness brand MyMuse raises $2.7M in Pre-Series A funding for nationwide expansion
